Aeterna Zentaris to Present at Upcoming Piper Jaffray and Oppenheimer Healthcare Conferences in New York

QUÉBEC CITY, Nov. 21, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that it will be presenting a Company overview at the two following healthcare conferences in New York City:

23^rd Annual Piper Jaffray Health Care Conference
Wednesday, November 30, 2011 at 12:30 p.m. (eastern)
New York Palace Hotel, New York City

Oppenheimer 22^nd Annual Healthcare Conference
Tuesday, December 13, 2011 at 2:10 p.m. (eastern)
West Foyer Room, Waldorf-Astoria Hotel, New York City

A live webcast of the Oppenheimer Healthcare Conference presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit www.aezsinc.com